Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Benefitfocus Announces Closing of Secondary Offering
-
Erickson to Present at the Canaccord Genuity 35th Annual Growth Conference
-
MEDIA ADVISORY - Oncolytics Biotech® Inc. to Participate in the 35th Annual Canaccord Genuity Growth Conference
-
Orsu Metals Corporation results for the period ended June 30, 2015 (Unaudited)
-
ZELTIQ to Present at the Canaccord Genuity 35th Annual Growth Conference
-
Endo Announces Appearance at Canaccord Genuity 35th Annual Growth Conference
-
Neovasc to Present at the Canaccord Genuity 35th Annual Growth Conference
-
Autobytel to Present at the 35th Annual Canaccord Genuity Growth Conference on August 13, 2015
-
Autobytel to Present at the 35th Annual Canaccord Genuity Growth Conference on August 13, 2015
-
The Chefs' Warehouse, Inc. to Present at the 35th Annual Canaccord Genuity Growth Conference
-
Optomec to Present at Canaccord Genuity Growth Conference
-
LSI Industries (LYTS) Provides Prelim Q4, FY Results
-
LSI Industries Inc. Announces Preliminary Operating Results for the Fourth Quarter and Fiscal Year Ended June 30, 2015
-
Notable Analyst Rating Changes 8/11: (ADBE) (RAX) (VZ) Upgraded; (AMAT) (KMT) (XON) Downgraded
-
Canaccord Genuity Starts Vermillion (VRML) at Buy
-
Demandware to Present at Upcoming Investor Conferences
-
Maxwell Technologies CEO Franz Fink To Present At Canaccord Genuity Investor Conference In Boston
-
Monotype to Present at the Canaccord Genuity 35th Annual Growth Conference
-
NuVasive to Participate in Upcoming Investor Event
-
Retail Opportunity Investments Corp. Announces Closing of Common Share Offering
-
Telenav to Present at Canaccord Genuity Conference
-
Transition Therapeutics to Present at the Canaccord Genuity 35th Annual Growth Conference
-
Adept Technology to Present at the Canaccord Genuity 35th Annual Growth Conference
-
ImmunoGen, Inc. Announces Canaccord Genuity Growth Conference Webcast
-
Datalink Corporation to Present at the Canaccord Genuity 35th Annual Growth Conference
-
Zynerba Pharmaceuticals Announces Closing of Its Initial Public Offering and Exercise in Full of Option to Purchase Additional Shares
-
Zynerba Pharmaceuticals Announces Closing of Its Initial Public Offering and Exercise in Full of Option to Purchase Additional Shares
-
Proto Labs, Inc. to Present at the 35th Annual Canaccord Genuity Growth Conference
-
GlycoMimetics to Present at the Canaccord Genuity Growth Conference
-
Canaccord Genuity Upgrades Pengrowth Energy Trust (PGH) to Buy
-
Notable Analyst Rating Changes 8/10: (NLSN) (TTMI) (OKS) Upgraded; (JD) (WLK) (GPS) Downgraded
-
Canaccord Genuity Cuts Price Target on OraSure Technologies (OSUR) Following 2Q Results and Guidance
-
Medifast, Inc. to Participate in the Canaccord Genuity 35th Annual Growth Conference
-
Imprivata to Present at the Canaccord Genuity Growth Conference
-
Sierra Wireless to Present at the Canaccord Genuity 35th Annual Growth Conference
-
Endologix to Present at the Canaccord Genuity 35th Annual Growth Conference
-
Carmanah Reports Second Quarter 2015 Results
-
Cancer Genetics (CGIX) Enters Purchase Agreement to Acquire Response Genetics (RGDX)
-
Response Genetics Inc. Enters Into Asset Purchase Agreement With Cancer Genetics Inc.; Proposed Transaction to be Effectuated Through Voluntary Chapter 11; Business Uninterrupted
-
SCYNEXIS, Inc. to Present at 35th Canaccord Genuity Annual Growth Conference
-
Canaccord Genuity Downgrades TELUS Corporation (TU) to Hold
-
Canaccord Genuity Starts Vonage (VG) at Buy
-
Canaccord Genuity Starts ShoreTel (SHOR) at Buy
-
Canaccord Genuity Starts RingCentral (RNG) at Buy
-
Canaccord Genuity Starts 8x8 (EGHT) at Buy
-
Canaccord Genuity Upgrades Ritchie Bros (RBA) to Buy
-
Aptose Biosciences to Present at Canaccord Genuity 35th Annual Growth Conference
-
GTT to Present at Pacific Crest, Canaccord Genuity and Oppenheimer Investor Conferences
-
Vanda Pharmaceuticals to Present at the Canaccord Genuity Annual Growth Conference
-
ePlus to Present at the Canaccord Genuity 35th Annual Growth Conference

